Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report) shares reached a new 52-week high on Tuesday . The stock traded as high as $6.40 and last traded at $6.28, with a volume of 3703682 shares changing hands. The stock had previously closed at $5.04.
Analysts Set New Price Targets
Separately, Needham & Company LLC boosted their price objective on shares of Curaleaf from $4.25 to $5.25 and gave the company a “buy” rating in a report on Thursday, March 7th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Curaleaf currently has an average rating of “Hold” and an average target price of $4.13.
Get Our Latest Research Report on CURLF
Curaleaf Price Performance
Curaleaf (OTCMKTS:CURLF – Get Free Report) last announced its quarterly earnings results on Wednesday, March 6th. The company reported ($0.01) EPS for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.04. Curaleaf had a negative net margin of 20.77% and a negative return on equity of 12.93%. The firm had revenue of $345.27 million during the quarter, compared to the consensus estimate of $336.64 million. As a group, analysts forecast that Curaleaf Holdings, Inc. will post -0.18 earnings per share for the current year.
About Curaleaf
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
See Also
- Five stocks we like better than Curaleaf
- What Makes a Stock a Good Dividend Stock?
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- The How And Why of Investing in Oil Stocks
- Hilton Demonstrates Asset Light is Right for Investors
- Dividend Payout Ratio Calculator
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.